New Medical Centre Alexandria results, Q1 2023
Net profit, assets, equity and cash flow for Q1 2023, against the same period a year earlier, from the published financial statements.
Net profit7.45 millionEGP · −40.1% vs the same period a year earlier
Total assets314 millionEGP · −13.2% vs the same period a year earlier
Shareholders' equity233 millionEGP · −11.0% vs the same period a year earlier
Operating cash flow-2.39 millionEGP · −113.7% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q1 2023 was about 7.45 million EGP, down −40.1% from 12.42 million EGP in Q1 2022.
- Total assets at the end of Q1 2023 were about 314 million EGP, and shareholders' equity about 233 million EGP.
- Operating cash flow for Q1 2023 was negative at 2.39 million EGP.
Key lines against the same period a year earlier
This periodQ1 2022Change
Net profit7.45 million12.42 million−40.1%
Gross profit88.77 million26.42 million+236.0%
Total assets314 million362 million−13.2%
Total liabilities80.58 million99.45 million−19.0%
Shareholders' equity233 million262 million−11.0%
Total liabilities and equity314 million362 million−13.2%
Operating cash flow-2.39 million17.41 million−113.7%
Investing cash flow-2.92 million23.85 million−112.2%
Financing cash flow25.16 million-1.74 million+1548.7%
Net change in cash19.85 million39.52 million−49.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy